Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients.

Vittorio SchweigerPaola BellamoliFrancesco TausLeonardo GottinAlvise MartiniMarta NizzeroEleonora BonoraGiovanna Del BalzoKatia DonadelloErica SecchettinGabriele FincoDaniele De SantisEnrico Polati

Published in: Journal of clinical medicine (2024)

this retrospective study comes out in favor of both significant efficacy and safety of anti-CGRP and anti-CGRP receptors mAbs in migraine patients. Further methodologically stronger studies are necessary to validate our observation.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes